Titre : Noyaux gris centraux

Noyaux gris centraux : Questions médicales fréquentes

Termes MeSH sélectionnés :

Surgeons

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une dysfonction des noyaux gris centraux ?

Un diagnostic repose sur l'examen neurologique, l'imagerie cérébrale et l'historique médical.
Dyskinésie Imagerie par résonance magnétique Évaluation neurologique
#2

Quels tests sont utilisés pour évaluer les noyaux gris centraux ?

Les tests incluent l'IRM, le scanner et des évaluations fonctionnelles spécifiques.
Imagerie par résonance magnétique Tomodensitométrie Évaluation fonctionnelle
#3

Quels signes cliniques indiquent une atteinte des noyaux gris centraux ?

Les signes incluent des tremblements, une rigidité musculaire et des troubles de la coordination.
Tremblement Rigidité musculaire Troubles de la coordination
#4

Les tests génétiques sont-ils utiles pour le diagnostic ?

Oui, ils peuvent aider à identifier des maladies héréditaires affectant les noyaux gris centraux.
Tests génétiques Maladies héréditaires Dystonie
#5

Quelle est l'importance de l'historique médical dans le diagnostic ?

L'historique médical aide à identifier des antécédents familiaux ou des symptômes précurseurs.
Antécédents médicaux Symptômes précurseurs Évaluation clinique

Symptômes 5

#1

Quels sont les symptômes courants des troubles des noyaux gris centraux ?

Les symptômes incluent des mouvements involontaires, des troubles de l'équilibre et de la posture.
Mouvements involontaires Troubles de l'équilibre Posture
#2

Comment se manifestent les troubles de la coordination ?

Ils se manifestent par des difficultés à exécuter des mouvements précis et fluides.
Coordination Mouvements précis Difficultés motrices
#3

Les troubles de la parole sont-ils liés aux noyaux gris centraux ?

Oui, des troubles de la parole peuvent survenir en raison de dysfonctionnements dans ces structures.
Troubles de la parole Dysfonctionnement Noyaux gris centraux
#4

Les changements d'humeur peuvent-ils être un symptôme ?

Oui, des changements d'humeur et des troubles cognitifs peuvent être associés à ces troubles.
Changements d'humeur Troubles cognitifs Dysfonctionnement cérébral
#5

Quelles sont les manifestations de la rigidité musculaire ?

La rigidité musculaire se traduit par une résistance accrue aux mouvements passifs des membres.
Rigidité musculaire Mouvements passifs Symptômes moteurs

Prévention 5

#1

Peut-on prévenir les troubles des noyaux gris centraux ?

Certaines mesures de style de vie, comme l'exercice régulier, peuvent réduire les risques.
Prévention Exercice régulier Style de vie
#2

Quel rôle joue l'alimentation dans la prévention ?

Une alimentation équilibrée riche en antioxydants peut contribuer à la santé cérébrale.
Alimentation équilibrée Antioxydants Santé cérébrale
#3

Le contrôle du stress peut-il aider à prévenir ces troubles ?

Oui, la gestion du stress peut réduire le risque de troubles neurologiques.
Contrôle du stress Prévention Troubles neurologiques
#4

L'éducation sur les symptômes est-elle importante ?

Oui, une éducation précoce sur les symptômes peut favoriser un diagnostic rapide.
Éducation Symptômes Diagnostic rapide
#5

Les activités cognitives peuvent-elles prévenir les troubles ?

Oui, les activités cognitives stimulantes peuvent aider à maintenir la santé cérébrale.
Activités cognitives Santé cérébrale Prévention

Traitements 5

#1

Quels traitements sont disponibles pour les troubles des noyaux gris centraux ?

Les traitements incluent des médicaments, la thérapie physique et, dans certains cas, la chirurgie.
Médicaments Thérapie physique Chirurgie
#2

Les médicaments peuvent-ils soulager les symptômes ?

Oui, des médicaments comme les anticholinergiques et les dopaminergiques peuvent aider.
Anticholinergiques Dopaminergiques Symptômes
#3

Quand la chirurgie est-elle envisagée ?

La chirurgie est envisagée lorsque les traitements médicamenteux ne sont pas efficaces.
Chirurgie Traitement médicamenteux Efficacité
#4

La thérapie physique est-elle bénéfique ?

Oui, elle aide à améliorer la mobilité et à réduire les symptômes moteurs.
Thérapie physique Mobilité Symptômes moteurs
#5

Quels sont les effets des thérapies complémentaires ?

Les thérapies complémentaires peuvent aider à gérer le stress et améliorer le bien-être général.
Thérapies complémentaires Gestion du stress Bien-être

Complications 5

#1

Quelles complications peuvent survenir avec ces troubles ?

Les complications incluent des chutes, des blessures et des troubles de la déglutition.
Complications Chutes Troubles de la déglutition
#2

Les troubles cognitifs sont-ils une complication fréquente ?

Oui, des troubles cognitifs peuvent survenir, affectant la mémoire et la concentration.
Troubles cognitifs Mémoire Concentration
#3

Comment les troubles de la marche peuvent-ils affecter la vie quotidienne ?

Ils peuvent limiter l'autonomie et augmenter le risque de chutes et d'accidents.
Troubles de la marche Autonomie Accidents
#4

Les complications psychologiques sont-elles possibles ?

Oui, des complications comme l'anxiété et la dépression peuvent survenir.
Complications psychologiques Anxiété Dépression
#5

Les complications peuvent-elles affecter la qualité de vie ?

Oui, elles peuvent réduire la qualité de vie en limitant les activités quotidiennes.
Qualité de vie Activités quotidiennes Complications

Facteurs de risque 5

#1

Quels sont les facteurs de risque pour les troubles des noyaux gris centraux ?

Les facteurs incluent l'âge, des antécédents familiaux et certaines maladies neurologiques.
Facteurs de risque Âge Maladies neurologiques
#2

Le mode de vie influence-t-il le risque ?

Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque.
Mode de vie Sédentarité Alimentation
#3

Les traumatismes crâniens sont-ils un facteur de risque ?

Oui, les traumatismes crâniens peuvent augmenter le risque de troubles neurologiques.
Traumatismes crâniens Facteurs de risque Troubles neurologiques
#4

Les maladies auto-immunes peuvent-elles jouer un rôle ?

Oui, certaines maladies auto-immunes peuvent affecter les noyaux gris centraux.
Maladies auto-immunes Facteurs de risque Noyaux gris centraux
#5

L'exposition à des toxines est-elle un risque ?

Oui, l'exposition à certaines toxines environnementales peut augmenter le risque.
Toxines Exposition environnementale Facteurs de risque
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Noyaux gris centraux : Questions médicales les plus fréquentes", "headline": "Noyaux gris centraux : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Noyaux gris centraux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-25", "dateModified": "2025-02-19", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Noyaux gris centraux" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Cerveau", "url": "https://questionsmedicales.fr/mesh/D054022", "about": { "@type": "MedicalCondition", "name": "Cerveau", "code": { "@type": "MedicalCode", "code": "D054022", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Amygdale (système limbique)", "alternateName": "Amygdala", "url": "https://questionsmedicales.fr/mesh/D000679", "about": { "@type": "MedicalCondition", "name": "Amygdale (système limbique)", "code": { "@type": "MedicalCode", "code": "D000679", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.152" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Groupe nucléaire basolatéral", "alternateName": "Basolateral Nuclear Complex", "url": "https://questionsmedicales.fr/mesh/D066272", "about": { "@type": "MedicalCondition", "name": "Groupe nucléaire basolatéral", "code": { "@type": "MedicalCode", "code": "D066272", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.152.500" } } }, { "@type": "MedicalWebPage", "name": "Noyau central de l'amygdale", "alternateName": "Central Amygdaloid Nucleus", "url": "https://questionsmedicales.fr/mesh/D066274", "about": { "@type": "MedicalCondition", "name": "Noyau central de l'amygdale", "code": { "@type": "MedicalCode", "code": "D066274", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.152.750" } } }, { "@type": "MedicalWebPage", "name": "Groupe nucléaire cortico-médial", "alternateName": "Corticomedial Nuclear Complex", "url": "https://questionsmedicales.fr/mesh/D066276", "about": { "@type": "MedicalCondition", "name": "Groupe nucléaire cortico-médial", "code": { "@type": "MedicalCode", "code": "D066276", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.152.875" } } } ] }, { "@type": "MedicalWebPage", "name": "Claustrum", "alternateName": "Claustrum", "url": "https://questionsmedicales.fr/mesh/D000079482", "about": { "@type": "MedicalCondition", "name": "Claustrum", "code": { "@type": "MedicalCode", "code": "D000079482", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.320" } } }, { "@type": "MedicalWebPage", "name": "Corps strié", "alternateName": "Corpus Striatum", "url": "https://questionsmedicales.fr/mesh/D003342", "about": { "@type": "MedicalCondition", "name": "Corps strié", "code": { "@type": "MedicalCode", "code": "D003342", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.487" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Globus pallidus", "alternateName": "Globus Pallidus", "url": "https://questionsmedicales.fr/mesh/D005917", "about": { "@type": "MedicalCondition", "name": "Globus pallidus", "code": { "@type": "MedicalCode", "code": "D005917", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.487.397" } } }, { "@type": "MedicalWebPage", "name": "Néostriatum", "alternateName": "Neostriatum", "url": "https://questionsmedicales.fr/mesh/D017072", "about": { "@type": "MedicalCondition", "name": "Néostriatum", "code": { "@type": "MedicalCode", "code": "D017072", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.487.550" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Noyau caudé", "alternateName": "Caudate Nucleus", "url": "https://questionsmedicales.fr/mesh/D002421", "about": { "@type": "MedicalCondition", "name": "Noyau caudé", "code": { "@type": "MedicalCode", "code": "D002421", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.487.550.184" } } }, { "@type": "MedicalWebPage", "name": "Putamen", "alternateName": "Putamen", "url": "https://questionsmedicales.fr/mesh/D011699", "about": { "@type": "MedicalCondition", "name": "Putamen", "code": { "@type": "MedicalCode", "code": "D011699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.487.550.784" } } } ] }, { "@type": "MedicalWebPage", "name": "Noyau caudé", "alternateName": "Caudate Nucleus", "url": "https://questionsmedicales.fr/mesh/D002421", "about": { "@type": "MedicalCondition", "name": "Noyau caudé", "code": { "@type": "MedicalCode", "code": "D002421", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.487.550.184" } } }, { "@type": "MedicalWebPage", "name": "Putamen", "alternateName": "Putamen", "url": "https://questionsmedicales.fr/mesh/D011699", "about": { "@type": "MedicalCondition", "name": "Putamen", "code": { "@type": "MedicalCode", "code": "D011699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.487.550.784" } } }, { "@type": "MedicalWebPage", "name": "Striatum ventral", "alternateName": "Ventral Striatum", "url": "https://questionsmedicales.fr/mesh/D066328", "about": { "@type": "MedicalCondition", "name": "Striatum ventral", "code": { "@type": "MedicalCode", "code": "D066328", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.487.775" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Noyau accumbens", "alternateName": "Nucleus Accumbens", "url": "https://questionsmedicales.fr/mesh/D009714", "about": { "@type": "MedicalCondition", "name": "Noyau accumbens", "code": { "@type": "MedicalCode", "code": "D009714", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.487.775.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Noyau accumbens", "alternateName": "Nucleus Accumbens", "url": "https://questionsmedicales.fr/mesh/D009714", "about": { "@type": "MedicalCondition", "name": "Noyau accumbens", "code": { "@type": "MedicalCode", "code": "D009714", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.487.775.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Substance innominée", "alternateName": "Substantia Innominata", "url": "https://questionsmedicales.fr/mesh/D013377", "about": { "@type": "MedicalCondition", "name": "Substance innominée", "code": { "@type": "MedicalCode", "code": "D013377", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.880" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Noyau basal de Meynert", "alternateName": "Basal Nucleus of Meynert", "url": "https://questionsmedicales.fr/mesh/D020532", "about": { "@type": "MedicalCondition", "name": "Noyau basal de Meynert", "code": { "@type": "MedicalCode", "code": "D020532", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.880.100" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Noyaux gris centraux", "alternateName": "Basal Ganglia", "code": { "@type": "MedicalCode", "code": "D001479", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Clara Rodriguez-Sabate", "url": "https://questionsmedicales.fr/author/Clara%20Rodriguez-Sabate", "affiliation": { "@type": "Organization", "name": "Laboratory of Neurobiology and Experimental Neurology, Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, Tenerife, Canary Islands, Spain." } }, { "@type": "Person", "name": "Ingrid Morales", "url": "https://questionsmedicales.fr/author/Ingrid%20Morales", "affiliation": { "@type": "Organization", "name": "Laboratory of Neurobiology and Experimental Neurology, Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, Tenerife, Canary Islands, Spain." } }, { "@type": "Person", "name": "Manuel Rodriguez", "url": "https://questionsmedicales.fr/author/Manuel%20Rodriguez", "affiliation": { "@type": "Organization", "name": "Laboratory of Neurobiology and Experimental Neurology, Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, Tenerife, Canary Islands, Spain. mrdiaz@ull.edu.es." } }, { "@type": "Person", "name": "Sachin Manjunath", "url": "https://questionsmedicales.fr/author/Sachin%20Manjunath", "affiliation": { "@type": "Organization", "name": "Aster Medcity, Kochi, India." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Accuracy of robotic-assisted pedicle screw placement comparing junior surgeons with expert surgeons: Can junior surgeons place pedicle screws as accurately as expert surgeons?", "datePublished": "2022-07-19", "url": "https://questionsmedicales.fr/article/35864030", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jos.2022.06.012" } }, { "@type": "ScholarlyArticle", "name": "Survey of New Zealand Arthroplasty Surgeons on Surgeon-Level Outcome Reporting.", "datePublished": "2023-06-04", "url": "https://questionsmedicales.fr/article/37279844", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.arth.2023.05.069" } }, { "@type": "ScholarlyArticle", "name": "Does surgeon specialization add value to surgeon volume in gastric cancer surgery?", "datePublished": "2023-09-21", "url": "https://questionsmedicales.fr/article/37757682", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ejso.2023.107091" } }, { "@type": "ScholarlyArticle", "name": "Can the surgeon prolong the remaining life of the patient in pancreaticoduodenectomy surgery? or Is the surgeon helpless?", "datePublished": "2022-05-23", "url": "https://questionsmedicales.fr/article/35259757", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.24875/CIRU.21000683" } }, { "@type": "ScholarlyArticle", "name": "Ethnic and Racial Diversity Among Surgeon and Non-Surgeon Deans of Allopathic Medical Schools.", "datePublished": "2022-09-15", "url": "https://questionsmedicales.fr/article/36113434", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/00031348221117036" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Système nerveux", "item": "https://questionsmedicales.fr/mesh/D009420" }, { "@type": "ListItem", "position": 3, "name": "Système nerveux central", "item": "https://questionsmedicales.fr/mesh/D002490" }, { "@type": "ListItem", "position": 4, "name": "Encéphale", "item": "https://questionsmedicales.fr/mesh/D001921" }, { "@type": "ListItem", "position": 5, "name": "Prosencéphale", "item": "https://questionsmedicales.fr/mesh/D016548" }, { "@type": "ListItem", "position": 6, "name": "Télencéphale", "item": "https://questionsmedicales.fr/mesh/D013687" }, { "@type": "ListItem", "position": 7, "name": "Cerveau", "item": "https://questionsmedicales.fr/mesh/D054022" }, { "@type": "ListItem", "position": 8, "name": "Noyaux gris centraux", "item": "https://questionsmedicales.fr/mesh/D001479" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Noyaux gris centraux - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Noyaux gris centraux", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Noyaux gris centraux", "description": "Comment diagnostiquer une dysfonction des noyaux gris centraux ?\nQuels tests sont utilisés pour évaluer les noyaux gris centraux ?\nQuels signes cliniques indiquent une atteinte des noyaux gris centraux ?\nLes tests génétiques sont-ils utiles pour le diagnostic ?\nQuelle est l'importance de l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Surgeons#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Noyaux gris centraux", "description": "Quels sont les symptômes courants des troubles des noyaux gris centraux ?\nComment se manifestent les troubles de la coordination ?\nLes troubles de la parole sont-ils liés aux noyaux gris centraux ?\nLes changements d'humeur peuvent-ils être un symptôme ?\nQuelles sont les manifestations de la rigidité musculaire ?", "url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Surgeons#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Noyaux gris centraux", "description": "Peut-on prévenir les troubles des noyaux gris centraux ?\nQuel rôle joue l'alimentation dans la prévention ?\nLe contrôle du stress peut-il aider à prévenir ces troubles ?\nL'éducation sur les symptômes est-elle importante ?\nLes activités cognitives peuvent-elles prévenir les troubles ?", "url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Surgeons#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Noyaux gris centraux", "description": "Quels traitements sont disponibles pour les troubles des noyaux gris centraux ?\nLes médicaments peuvent-ils soulager les symptômes ?\nQuand la chirurgie est-elle envisagée ?\nLa thérapie physique est-elle bénéfique ?\nQuels sont les effets des thérapies complémentaires ?", "url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Surgeons#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Noyaux gris centraux", "description": "Quelles complications peuvent survenir avec ces troubles ?\nLes troubles cognitifs sont-ils une complication fréquente ?\nComment les troubles de la marche peuvent-ils affecter la vie quotidienne ?\nLes complications psychologiques sont-elles possibles ?\nLes complications peuvent-elles affecter la qualité de vie ?", "url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Surgeons#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Noyaux gris centraux", "description": "Quels sont les facteurs de risque pour les troubles des noyaux gris centraux ?\nLe mode de vie influence-t-il le risque ?\nLes traumatismes crâniens sont-ils un facteur de risque ?\nLes maladies auto-immunes peuvent-elles jouer un rôle ?\nL'exposition à des toxines est-elle un risque ?", "url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Surgeons#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction des noyaux gris centraux ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic repose sur l'examen neurologique, l'imagerie cérébrale et l'historique médical." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les noyaux gris centraux ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent l'IRM, le scanner et des évaluations fonctionnelles spécifiques." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une atteinte des noyaux gris centraux ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des tremblements, une rigidité musculaire et des troubles de la coordination." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils utiles pour le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent aider à identifier des maladies héréditaires affectant les noyaux gris centraux." } }, { "@type": "Question", "name": "Quelle est l'importance de l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier des antécédents familiaux ou des symptômes précurseurs." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des troubles des noyaux gris centraux ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des mouvements involontaires, des troubles de l'équilibre et de la posture." } }, { "@type": "Question", "name": "Comment se manifestent les troubles de la coordination ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils se manifestent par des difficultés à exécuter des mouvements précis et fluides." } }, { "@type": "Question", "name": "Les troubles de la parole sont-ils liés aux noyaux gris centraux ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles de la parole peuvent survenir en raison de dysfonctionnements dans ces structures." } }, { "@type": "Question", "name": "Les changements d'humeur peuvent-ils être un symptôme ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des changements d'humeur et des troubles cognitifs peuvent être associés à ces troubles." } }, { "@type": "Question", "name": "Quelles sont les manifestations de la rigidité musculaire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "La rigidité musculaire se traduit par une résistance accrue aux mouvements passifs des membres." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles des noyaux gris centraux ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines mesures de style de vie, comme l'exercice régulier, peuvent réduire les risques." } }, { "@type": "Question", "name": "Quel rôle joue l'alimentation dans la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée riche en antioxydants peut contribuer à la santé cérébrale." } }, { "@type": "Question", "name": "Le contrôle du stress peut-il aider à prévenir ces troubles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la gestion du stress peut réduire le risque de troubles neurologiques." } }, { "@type": "Question", "name": "L'éducation sur les symptômes est-elle importante ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une éducation précoce sur les symptômes peut favoriser un diagnostic rapide." } }, { "@type": "Question", "name": "Les activités cognitives peuvent-elles prévenir les troubles ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les activités cognitives stimulantes peuvent aider à maintenir la santé cérébrale." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les troubles des noyaux gris centraux ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments, la thérapie physique et, dans certains cas, la chirurgie." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils soulager les symptômes ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des médicaments comme les anticholinergiques et les dopaminergiques peuvent aider." } }, { "@type": "Question", "name": "Quand la chirurgie est-elle envisagée ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie est envisagée lorsque les traitements médicamenteux ne sont pas efficaces." } }, { "@type": "Question", "name": "La thérapie physique est-elle bénéfique ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle aide à améliorer la mobilité et à réduire les symptômes moteurs." } }, { "@type": "Question", "name": "Quels sont les effets des thérapies complémentaires ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les thérapies complémentaires peuvent aider à gérer le stress et améliorer le bien-être général." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec ces troubles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des chutes, des blessures et des troubles de la déglutition." } }, { "@type": "Question", "name": "Les troubles cognitifs sont-ils une complication fréquente ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles cognitifs peuvent survenir, affectant la mémoire et la concentration." } }, { "@type": "Question", "name": "Comment les troubles de la marche peuvent-ils affecter la vie quotidienne ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent limiter l'autonomie et augmenter le risque de chutes et d'accidents." } }, { "@type": "Question", "name": "Les complications psychologiques sont-elles possibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications comme l'anxiété et la dépression peuvent survenir." } }, { "@type": "Question", "name": "Les complications peuvent-elles affecter la qualité de vie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent réduire la qualité de vie en limitant les activités quotidiennes." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les troubles des noyaux gris centraux ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, des antécédents familiaux et certaines maladies neurologiques." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque." } }, { "@type": "Question", "name": "Les traumatismes crâniens sont-ils un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traumatismes crâniens peuvent augmenter le risque de troubles neurologiques." } }, { "@type": "Question", "name": "Les maladies auto-immunes peuvent-elles jouer un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies auto-immunes peuvent affecter les noyaux gris centraux." } }, { "@type": "Question", "name": "L'exposition à des toxines est-elle un risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à certaines toxines environnementales peut augmenter le risque." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 19/02/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

None None

3 publications dans cette catégorie

Publications dans "Noyaux gris centraux" :

Clara Rodriguez-Sabate

2 publications dans cette catégorie

Affiliations :
  • Laboratory of Neurobiology and Experimental Neurology, Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, Tenerife, Canary Islands, Spain.
  • Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • Department of Psychiatry, Getafe University Hospital, Madrid, Spain.
Publications dans "Noyaux gris centraux" :

Ingrid Morales

2 publications dans cette catégorie

Affiliations :
  • Laboratory of Neurobiology and Experimental Neurology, Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, Tenerife, Canary Islands, Spain.
  • Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
Publications dans "Noyaux gris centraux" :

Manuel Rodriguez

2 publications dans cette catégorie

Affiliations :
  • Laboratory of Neurobiology and Experimental Neurology, Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, Tenerife, Canary Islands, Spain. mrdiaz@ull.edu.es.
  • Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. mrdiaz@ull.edu.es.
Publications dans "Noyaux gris centraux" :

Sachin Manjunath

2 publications dans cette catégorie

Affiliations :
  • Aster Medcity, Kochi, India.
Publications dans "Noyaux gris centraux" :

Boby Varkey Maramattom

2 publications dans cette catégorie

Affiliations :
  • Aster Medcity, Kochi, India.
Publications dans "Noyaux gris centraux" :

Shagos Gn Santhamma

2 publications dans cette catégorie

Affiliations :
  • Aster Medcity, Kochi, India.
Publications dans "Noyaux gris centraux" :

Andrea Accogli

2 publications dans cette catégorie

Affiliations :
  • From the Department of Brain and Behavioural Neurosciences (S.M., A.P., M. Formica, S.O.) and Department of Public Health Experimental and Forensic Medicine, Biostatistic and Clinical Epidemiology Unit (P. Borrelli), University of Pavia; Pediatric Neurology Unit (S.M., M. Mastrangelo, P.V.), V. Buzzi Children's Hospital, Milan; Department of Neuroradiology (A.P.), Child Neurology and Psychiatry Unit (R.B., V.D.G., S.O.), and Department of Internal Medicine and Therapeutics, Member of the ERN EpiCARE, University of Pavia and Clinical Trial Center (E.P.), IRCCS Mondino Foundation Pavia; Neuroimaging Lab (F.A.) and Neuropsychiatry and Neurorehabilitation Unit (R.R.), Scientific Institute, IRCCS Eugenio Medea, Bosisio Parini, Lecco; Child Neuropsychiatric Unit (P.A., L.G.), Civilian Hospital, Brescia; Scientific Institute (P. Bonanni, A.D., E.O.), IRCCS E. Medea, Epilepsy and Clinical Neurophysiology Unit, Conegliano, Treviso; UOC Child Neuropsychiatry (B.D.B., F.D.), Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Italy; Département de Neurologie Pédiatrique (N.D.), Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Belgium; AdPueriVitam (O.D.), Antony; Service d'Explorations Fonctionnelles (S.G.), Centre de Médecine du Sommeil, l'Hôpital Àntoine Béclère, AP-HP, Clamart; Pediatrics Departement (S.G.), André-Grégoire Hospital, Centre Hospitalier Inter Communal, Montreuil, France; Pediatric Neurology, Neurogenetics and Neurobiology Unit and Laboratories, Neuroscience Department (R.G., M. Montomoli, M.C.) and Radiology (M. Mortilla), A. Meyer Children's Hospital, Member of the ERN EpiCARE, University of Florence; IRCCS Stella Maris Foundation (R.G.), Pisa; Child Neuropsychiatry Unit, Epilepsy Center (F.L.B., A.V.), San Paolo Hospital, Department of Health Sciences, Università degli Studi di Milano, Milan; Child Neurology, NESMOS Department (P.P.), Faculty of Medicine & Psychology, Sant'Andrea Hospital, Sapienza University, Rome; Department of Neuroradiology (L.P.), Pediatric Neuroradiology Section, ASST Spedali Civili, Brescia; Pediatric Neuroradiology Unit (M.S.), IRCCS Istituto Giannina Gaslini, Genova; Neurology Unit, Department of Neuroscience, Member of the ERN EpiCARE (F.V.), Oncological Neuroradiology Unit, Department of Imaging, IRCCS (G.C.), and Department of Neuroscience and Neurorehabilitation (A.F.), Bambino Gesù Children's Hospital, Rome, Italy; Institut Imagine (N.B.-B.), Université Paris Descartes-Sorbonne Paris Cités; Pediatric Neurology (N.B.-B., I.D.), Necker Enfants Malades Hospital, Member of the ERN EpiCARE, Assistance Publique-Hôpitaux de Paris; INSERM UMR-1163 (N.B.-B., A. Arzimanoglou), Embryology and Genetics of Congenital Malformations, France; UOC Neurochirurgia (A. Accogli, V.C.), Pediatric Neurology and Muscular Diseases Unit, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa (F.Z.), and Laboratory of Neurogenetics and Neuroscience, IRCCS (F.Z.), Istituto Giannina Gaslini, Genoa, Italy; Neurochirurgie Pédiatrique (M.B.), Hôpital NEM, Paris, France; Centre Médico-Chirurgical des Eaux-Vives (V.C.-V.), Swiss Medical Network, Genève, Switzerland; Neuroradiology Unit (L.C.) and Developmental Neurology Unit (S.D.), Foundation IRCCS C. Besta Neurological Institute, Milan; Service de Génétique (M.D.-F.), AMH2, CHU Reims, UFR de Médecine, Reims, France; Epilepsy Centre-Clinic of Nervous System Diseases (G.d.), Riuniti Hospital, Foggia, Italy; MediClubGeorgia Co Ltd (N.E.), Tbilisi, Georgia; Epilepsy Center (N.E.), Medical Center, Faculty of Medicine, University of Freiburg, Germany; Child and Adolescence Neurology and Psychiatry Unit (E. Fazzi), ASST Civil Hospital, Department of Clinical and Experimental Sciences, University of Brescia; Child Neurology Department (E. Fiorini), Verona, Italy; Service de Genetique Clinique (M. Fradin, P.L., C.Q.), CLAD-Ouest, Hospital Sud, Rennes, France; Child Neurology Unit, Pediatric Department (C.F., C.S.), Azienda USL-IRCCS di Reggio Emilia; Department of Pediatric Neuroscience (T.G., R.S.), Fondazione IRCCS Istituto Neurologico Carlo Besta, Member of the ERN EpiCARE, Milan, Italy; Department of Epilepsy Genetics and Personalized Treatment (K.M.J., R.S.M.), The Danish Epilepsy Centre, Dianalund; Institute for Regional Health Services (K.M.J., R.S.M.), University of Southern Denmark, Odense; Unit of Pediatric Neurology and Pediatric Neurorehabilitation (S.L.), Woman-Mother-Child Department, Lausanne University Hospital CHUV, Switzerland; Unit of Neuroradiology (D.M.), Fondazione CNR/Regione Toscana G. Monasterio, Pisa; Pediatric Neurology Unit and Epilepsy Center (E.R., A.R.), Fatebenefratelli Hospital, Milan, Italy; KJF Klinik Josefinum GmbH (C.U.), Klinik für Kinder und Jugendliche, Neuropädiatrie, Augsburg, Germany; Department of Paediatric Clinical Epileptology, Sleep Disorders and Functional Neurology (A. Arzimanoglou), University Hospitals of Lyon, Coordinator of the ERN EpiCARE, France; and Pediatric Epilepsy Unit, Child Neurology Department (P.V.), Hospital San Juan de Dios, Member of the ERN EpiCARE and Universitat de Barcelona, Spain.
Publications dans "Noyaux gris centraux" :

Kevin Gurney

2 publications dans cette catégorie

Affiliations :
  • Department of Psychology, The University of Sheffield, Sheffield S1 2LT, UK.
Publications dans "Noyaux gris centraux" :

Jannik Prasuhn

2 publications dans cette catégorie

Affiliations :
  • Department of Neurology, University Medical Center Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
  • Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
Publications dans "Noyaux gris centraux" :

Norbert Brüggemann

2 publications dans cette catégorie

Affiliations :
  • Department of Neurology, University Medical Center Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
  • Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
Publications dans "Noyaux gris centraux" :

E Auffray-Calvier

1 publication dans cette catégorie

Affiliations :
  • Service de neuroradiologie, hôpital René-et-Guillaume-Laënnec, boulevard Jacques-Monod, 44093 Saint-Herblain cedex 1, France. Electronic address: elisabeth.calvier@chu-nantes.fr.
Publications dans "Noyaux gris centraux" :

A Lintia-Gaultier

1 publication dans cette catégorie

Affiliations :
  • Service de neuroradiologie, hôpital René-et-Guillaume-Laënnec, boulevard Jacques-Monod, 44093 Saint-Herblain cedex 1, France.
Publications dans "Noyaux gris centraux" :

R Bourcier

1 publication dans cette catégorie

Affiliations :
  • Service de neuroradiologie, hôpital René-et-Guillaume-Laënnec, boulevard Jacques-Monod, 44093 Saint-Herblain cedex 1, France.
Publications dans "Noyaux gris centraux" :

J Aguilar Garcia

1 publication dans cette catégorie

Affiliations :
  • Service de neuroradiologie, hôpital René-et-Guillaume-Laënnec, boulevard Jacques-Monod, 44093 Saint-Herblain cedex 1, France.
Publications dans "Noyaux gris centraux" :

Ho Xuan Tuan

1 publication dans cette catégorie

Affiliations :
  • Department of Medical Imaging, Da Nang University of Medical Technology and Pharmacy, Danang, Vietnam.
Publications dans "Noyaux gris centraux" :

Nguyen-Thi Huyen

1 publication dans cette catégorie

Affiliations :
  • Radiology Center, Bach Mai Hospital, Hanoi, Vietnam.
Publications dans "Noyaux gris centraux" :

Nguyen Duc Son

1 publication dans cette catégorie

Affiliations :
  • Department of Radiology, Hanoi Medical University, Hanoi, Vietnam.
Publications dans "Noyaux gris centraux" :

Nguyen Viet Trung

1 publication dans cette catégorie

Affiliations :
  • Pathology and Cytology Center, Bach Mai hospital, Hanoi, Vietnam.
Publications dans "Noyaux gris centraux" :

Nguyen-Thi Hai Anh

1 publication dans cette catégorie

Affiliations :
  • Department of Radiology, Alexandra Lepève Hospital, Dunkirk, France.
Publications dans "Noyaux gris centraux" :

Sources (3583 au total)

Accuracy of robotic-assisted pedicle screw placement comparing junior surgeons with expert surgeons: Can junior surgeons place pedicle screws as accurately as expert surgeons?

The purpose of this study was to verify whether a spine robotic system was useful for junior surgeons.... Twenty-seven patients underwent posterior spinal fusion with open surgery using a spine robotic system (Mazor X Stealth Edition, Medtronic Inc., Dublin, Ireland) from April to August 2021. Pedicle scr... In the expert surgeon group, the GR grades were Grade A for 79 screws (90.8%), Grade B for 6 (6.9%), Grade C for 2 (2.3%), and 0 (0%) for Grades D and E. I In the junior surgeon group, the GR grades w... There were no significant differences in the deviation rate and the insertion time of robotic-assisted pedicle screw placement between expert surgeons and junior surgeons who were training to acquire ...

Survey of New Zealand Arthroplasty Surgeons on Surgeon-Level Outcome Reporting.

Surgeon-specific outcome monitoring has become increasingly prevalent over the last 3 decades. The New Zealand Orthopaedic Association monitors individual surgeon performance through 2 mechanisms: art... The survey consisted of 9 questions on surgeon-specific outcome reporting, using a five-point Likert scale, and 5 demographic questions. It was distributed to all current hip and knee arthroplasty sur... Respondents agreed that monitoring arthroplasty outcomes is important and that revision rates are an acceptable measure of performance. Reporting risk-adjusted revision rates and more recent timeframe... The findings of this survey support the use of revision rates to confidentially monitor surgeon-level arthroplasty outcomes and suggest that concurrent use of patient-reported outcome measures would b...

Does surgeon specialization add value to surgeon volume in gastric cancer surgery?

This study aimed to assess the combined impact of surgeon specialization and surgeon volume on both short- and long-term outcomes in patients underwent curative gastrectomy for gastric cancer.... Patients with cStage1-3 gastric adenocarcinoma who underwent curative-intent surgery between January 2010 and December 2020 were evaluated. The impact of surgeon specialization and surgeon volume on c... Total of 537 patients operated by twelve surgeons were included in the analysis. For all cohort, the 30d-, in-hospital and 90d-mortality were 3.5%, 3%, and 6.3%, respectively. High surgeon volume alon... The primary factor influencing short-term outcomes for patients who underwent gastric cancer surgery was found to be surgeon volume, while specialization provided a limited additional value. However, ...

Can the surgeon prolong the remaining life of the patient in pancreaticoduodenectomy surgery? or Is the surgeon helpless?

We aimed to evaluate the effects of R0 and R1 resections after pancreatic surgery.... Data of 130 patients were evaluated. Re-resection was performed in patients who were found to have R1 resection after frozen section (FS). Overall survival (OS), disease free survival (DFS) among pati... Tumor diameter, differentiation, age and complications were found to negatively affect OS. It was observed that DFS increased (p:0.02) and local recurrence rates decreased (p:0.037) in group 2 compare... R0 resection obtained by surgical margin resection of the neck in pancreatic head adenocarcinomas decreases local recurrence and increases the duration of DFS. However, it has no effect on preventing ...

Ethnic and Racial Diversity Among Surgeon and Non-Surgeon Deans of Allopathic Medical Schools.

Previous publications have assessed the diversity among medical students, residents, faculty, and department leaders in surgery and medicine overall. We aim to evaluate the diversity among medical sch... 151 allopathic medical schools were included. Data regarding demographics, education, training, and previous leadership position were collected from institutional websites, online resources, and July ... 21.9% (n = 33) of all medical school deans were surgeons. 21.2% (n = 7) were women, which was not significantly different from non-surgeons (22%,... The demographic diversity of surgeon and non-surgeon US medical school deans is not significantly different. The deficiencies in leadership diversity in medicine persists among medical school deans. T...

Appendectomy by Pediatric Surgeons in North Carolina is Associated With Higher Charge Than General Surgeons.

The delivery of pediatric surgical care for acute appendicitis involves general surgeons (GS) and pediatric surgeons (PS), but the differences in clinical practice are primarily undescribed. We examin... We performed a retrospective review of the North Carolina hospital discharge database (2013-2017) in pediatric patients (≤18 y) who had surgery for appendiceal pathology (acute or chronic appendicitis... Over the study period, 21,049 patients had appendicitis or other diseases of the appendix, and 15,230 (72.4%) underwent appendectomy. Patients who were operated on by PS were younger (10 y, interquart... The total charge for operations for appendiceal disease is significantly higher for PS compared to GS. Pediatric surgeons had increased surgical charges compared to GS but decreased radiology charges....

The job market for HPB surgeons: leadership perspectives on surgeon skillsets, training pathways, and hiring.

Three tracks prepare Hepato-Pancreato-Biliary (HPB) surgeons: HPB, surgical oncology, and transplant fellowships. This study explored how surgical leaders thought about HPB surgery and evaluated poten... This descriptive qualitative study utilized interviews of healthcare leaders whose responsibilities included hiring HPB surgeons. We coded inductively then used thematic network analysis to organize t... Primary themes were: (1) What defines an HPB surgical practice?, (2) How do they assess candidates for HPB positions?, and (3) How will HPB practices continue to evolve? Leaders assessed applicants' t... Surgical societies should focus on facilitating networking, promoting transparency, sharing quality data, providing evidence of technical skills and teamwork, mentorship, and providing guidance to gen...

[What female surgeons wish for!]

Surgical specialties have a recruitment problem. A magnification of the problem is often seen in the "feminization" of medicine but the causes are multifactorial. Female physicians of the association ... An anonymized online survey was conducted internally within the association ("Die Chirurginnen e. V.") in October 2022. The survey contained a total of 57 questions and was divided into 7 sections (de... A total of 358 female surgeons participated in the survey. This represented a response rate of 25.5% of association members (as of October 2022: n = 1406). The mean age was 39.25 years (±8.06 years; r... Motivated and dedicated surgeons are needed to counteract the already existing and increasingly severe shortage of manpower. In recent decades, the proportion of female students and physicians has bee...

Becoming a Sustainable Academic Surgeon.

Health care facilities represent a significant source of pollution, contributing to the growing problems associated with global warming. The resulting climate change impacts our health through worseni... We outline here the not only the role of the surgeon in contributing to climate change, but also ways in which to minimize one's carbon footprint.... Surgeons are leaders within healthcare systems. Adopting environmentally conscious practices can reduce solid waste, energy usage, and carbon emissions. Practices outside of the clinical setting can a... Academic surgery combines clinical practice with an element of leadership, at all levels. Our recognition and action to reduce wasteful practices can help leave a better earth for generations to come....

Surgeon Volume and Laryngectomy Outcomes.

To examine the relationship between surgeon volume and operative morbidity and mortality for laryngectomy.... The Nationwide Inpatient Sample was used to identify 45,156 patients who underwent laryngectomy procedures for laryngeal or hypopharyngeal cancer between 2001 and 2011. Hospital and surgeon laryngecto... Relationships between hospital and surgeon volume and mortality, surgical complications, and acute medical complications were examined using multivariable regression.... Higher-volume surgeons were more likely to operate at large, teaching, nonprofit hospitals and were more likely to treat patients who were white, had private insurance, hypopharyngeal cancer, low como... There is a strong volume-outcome relationship for laryngectomy, with reduced mortality and morbidity associated with higher surgeon and higher hospital volumes. Observed associations between hospital ...